Tumor Infiltrating Lymphocytes: Clinical Trials

4 trials for Tumor Infiltrating Lymphocytes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Not yet recruiting 1, Recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Tumor Infiltrating Lymphocytes: new trials by email Literature Review of Tumor Infiltrating Lymphocytes trials Research Report on Tumor Infiltrating Lymphocytes

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
transfusion of 5×10^8 PD-1 knockout TILs per kg body weight, transfusion of 1×10^9 PD-1 edited TILs per kg body weight, transfusion of 2×10^9 PD-1 edited TILs per kg body weight - Colorectal Cancer (CRC), Tumor Infiltrating Lymphocytes
Phase 1RecruitingRuijin Hospital292024-12-312025-06-24
A Study of GC101 TIL in Advanced Melanoma (BZ)
GC101 TIL - Tumor Infiltrating Lymphocytes, Safety
Phase 1 / Phase 2CompletedShanghai Juncell Therapeutics182023-11-082025-12-23
A Phase I Study of GC101 TIL in Advanced Solid Tumors
TIL therapy - Tumor Infiltrating Lymphocytes, Safety
Phase 1CompletedShanghai Juncell Therapeutics432022-10-122025-12-10
Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer
Autologous tumor-infiltrating lymphocytes - Tumor Infiltrating Lymphocytes
Phase 1 / Phase 2Not yet recruitingWomen's Hospital School Of Medicine Zhejiang University912022-01-012021-12-10

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (2)  ·  Colorectal Neoplasms (1)  ·  Melanoma (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)

Sponsors

Shanghai Juncell Therapeutics (2)  ·  Ruijin Hospital (1)  ·  Women's Hospital School Of Medicine Zhejiang University (1)

Countries

China (3)

Top investigators

Hui Wang, MD (1)  ·  Jun Guo (1)